SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TD Cowen Downgrades Boston Scientific to Hold From Buy

TD Cowen cut its rating on Boston Scientific to Hold from Buy. The headline lists a $46 price target.

BSX

Related stories